Clovis Oncology (CLVS) Misses Q1 EPS by 6c

Clovis Oncology (NASDAQ: CLVS) reported Q1 EPS of ($0.91), $0.06 worse than the analyst estimate of ($0.85).

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c